Breast Biopsy Market Overview
The breast biopsy market is projected to reach USD 1104 million by 2027 at CAGR of 10.10%, says Market Research Future (MRFR). The development of novel biopsy techniques and the approval of new products enable minimally invasive procedures. A 6mm Bergstrom side-cutting biopsy needle was deemed successful for obtaining big amounts of tissue under ultrasound guidance. These new devices and procedures have had a substantial impact on the Breast biopsy market’s overall growth. Breast cancer incidences have been increasing in recent years, which is the key driver of the Breast biopsy market’s growth.
While identifying cancer cells and DNA fragments has been a hurdle in the medical business, the development of liquid biopsy has aided physicians in precisely identifying circulating tumor cells. Additionally, the method may remove the need for surgeries and their associated complications, such as scarring. The liquid biopsy is capable of identifying the genetic complexity of human breast cancers and also of preventing them from spreading to other parts of the body. These advantageous characteristics of liquid biopsy have created a profitable opportunity for the global Breast Biopsy Market to expand.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6288
Invasive operations involve a number of negative consequences, including significant blood loss, surgical infection, and prolonged recovery time. However, the development of minimally invasive procedures such as image-guided biopsy has resulted in more precise outcomes. Increased acceptance of image-guided needle biopsy is anticipated to propel the Breast Biopsy market forward during the forecast period. Numerous public and private organizations, industry players, and hospitals are launching unique initiatives to increase public awareness of breast cancer and the clinical benefits of early detection through screening programs. These endeavors to raise awareness about breast cancer early detection and diagnosis are projected to drive demand for breast biopsy systems, thereby propelling market expansion.
The coronavirus pandemic’s impact and the resulting shutdown are seen in a variety of businesses, including the breast biopsy market. The implementation of new standards and regulations is impeding this industry’s growth. Additionally, limited access to clinics, social isolation, and population lockdown, all of which result in a slowdown in patient flow and referrals, have harmed market growth.
Breast Biopsy Market Segmental Analysis
The market is categorized by product into Biopsy Needles and Biopsy Tables.
The market is categorized by technique type into Fine Needle Aspiration Biopsy and Core Needle Biopsy.
The breast biopsy market is categorized by Guidance Technology into Ultrasound-Guided and CT-Guided Biopsy. The market is categorized by End-Users into Hospitals, u7and Laboratories.
Breast Biopsy Market Regional Overview
North America now holds the lion’s share of the market, accounting for more than 42% in the year 2020. In recent years, the region has been diagnosed with more than 62% of breast cancer cases. The advancement of medical infrastructure and technology has aided in the region’s overall industry growth. Additionally, growing awareness of palpable breast masses, early detection, and self-examination has impacted the Breast Biopsy market’s growth.
The healthcare infrastructure in growing economies such as China, India, and South Korea is rapidly evolving, prompting hospitals and breast care centers to make significant expenditures in modern systems (including liquid breast biopsy and vacuum-assisted biopsy devices, among others). This factor is fueling the Asia-Pacific breast biopsy market’s expansion. Additionally, rising breast cancer prevalence, an increase in the number of awareness initiatives for early diagnosis of breast cancer, and increased government investment on breast cancer research studies all contribute to the growth of the breast biopsy market in Asia Pacific.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288
Breast Biopsy Market Competitive Dynamics
Leica Biosystems, C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Becton, Dickinson and Company, Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC., Johnson & Johnson, Galini SRL, Intact Medical Corporation, Conceptus INC, Hologic Inc., Karl Storz GmbH & Co. Kg, GE Healthcare
Browse Related Reports at:
Diabetic Retinopathy Market Research Report – Forecast to 2027
Arrhythmia Monitoring Devices Market Research Report – Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071